Search

Researchers and scientists can use computational-based models to turn linked data into useful information, aiding in disease diagnosis, examination, and viral containment due to recent artificial intelligence and machine learning breakthroughs. In this paper, we extensively study the role of artificial intelligence and machine learning in delivering efficient responses to the COVID-19 pandemic almost four years after its start. In this regard, we examine a large number of critical studies conducted by various academic and research communities from multiple disciplines, as well as practical implementations of artificial intelligence algorithms that suggest potential solutions in investigating different COVID-19 decision-making scenarios. We identify numerous areas where artificial intelligence and machine learning can impact this context, including diagnosis (using chest X-ray imaging and CT imaging), severity, tracking, treatment, and the drug industry. Furthermore, we analyse the dilemma's limits, restrictions, and hazards. [ABSTRACT FROM AUTHOR]

Coronavirus disease (COVID-19) is a viral pneumonia that originated in China and has rapidly spread around the world. Early diagnosis is important to provide effective and timely treatment. Thus, many studies have attempted to solve the COVID-19 classification problems of workload classification, disease detection, and differentiation from other types of pneumonia and healthy lungs using different radiological imaging modalities. To date, several researchers have investigated the problem of using deep learning methods to detect COVID-19, but there are still unsolved challenges in this field, which this review aims to identify. The existing research on the COVID-19 classification problem suffers from limitations due to the use of the binary or flat multiclass classification, and building classifiers based on only a few classes. Moreover, most prior studies have focused on a single feature modality and evaluated their systems using a small public dataset. These studies also show a reliance on diagnostic processes based on CT as the main imaging modality, ignoring chest X-rays, as explained below. Accordingly, the aim of this review is to examine existing methods and frameworks in the literature that have been used to detect and classify COVID-19, as well as to identify research gaps and highlight the limitations from a critical perspective. The paper concludes with a list of recommendations, which are expected to assist future researchers in improving the diagnostic process for COVID-19 in particular. This should help to develop effective radiological diagnostic data for clinical applications and to open future directions in this area in general. [ABSTRACT FROM AUTHOR]

Background: In medical diagnosis and clinical practice, diagnosing a disease early is crucial for accurate treatment, lessening the stress on the healthcare system. In medical imaging research, image processing techniques tend to be vital in analyzing and resolving diseases with a high degree of accuracy. This paper establishes a new image classification and segmentation method through simulation techniques, conducted over images of COVID-19 patients in India, introducing the use of Quantum Machine Learning (QML) in medical practice.Methods: This study establishes a prototype model for classifying COVID-19, comparing it with non-COVID pneumonia signals in Computed tomography (CT) images. The simulation work evaluates the usage of quantum machine learning algorithms, while assessing the efficacy for deep learning models for image classification problems, and thereby establishes performance quality that is required for improved prediction rate when dealing with complex clinical image data exhibiting high biases.Results: The study considers a novel algorithmic implementation leveraging quantum neural network (QNN). The proposed model outperformed the conventional deep learning models for specific classification task. The performance was evident because of the efficiency of quantum simulation and faster convergence property solving for an optimization problem for network training particularly for large-scale biased image classification task. The model run-time observed on quantum optimized hardware was 52 min, while on K80 GPU hardware it was 1 h 30 min for similar sample size. The simulation shows that QNN outperforms DNN, CNN, 2D CNN by more than 2.92% in gain in accuracy measure with an average recall of around 97.7%.Conclusion: The results suggest that quantum neural networks outperform in COVID-19 traits' classification task, comparing to deep learning w.r.t model efficacy and training time. However, a further study needs to be conducted to evaluate implementation scenarios by integrating the model within medical devices. [ABSTRACT FROM AUTHOR]

The universal transmission of pandemic COVID-19 (Coronavirus) causes an immediate need to commit in the fight across the whole human population. The emergencies for human health care are limited for this abrupt outbreak and abandoned environment. In this situation, inventive automation like computer vision (machine learning, deep learning, artificial intelligence), medical imaging (computed tomography, X-Ray) has developed an encouraging solution against COVID-19. In recent months, different techniques using image processing are done by various researchers. In this paper, a major review on image acquisition, segmentation, diagnosis, avoidance, and management are presented. An analytical comparison of the various proposed algorithm by researchers for coronavirus has been carried out. Also, challenges and motivation for research in the future to deal with coronavirus are indicated. The clinical impact and use of computer vision and deep learning were discussed and we hope that dermatologists may have better understanding of these areas from the study. [ABSTRACT FROM AUTHOR]

The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19, whereas the recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists. We hereby review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. For example, AI-empowered image acquisition can significantly help automate the scanning procedure and also reshape the workflow with minimal contact to patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate delineation of infections in X-ray and CT images, facilitating subsequent quantification. Moreover, the computer-aided platforms help radiologists make clinical decisions, i.e., for disease diagnosis, tracking, and prognosis. In this review paper, we thus cover the entire pipeline of medical imaging and analysis techniques involved with COVID-19, including image acquisition, segmentation, diagnosis, and follow-up. We particularly focus on the integration of AI with X-ray and CT, both of which are widely used in the frontline hospitals, in order to depict the latest progress of medical imaging and radiology fighting against COVID-19. [ABSTRACT FROM AUTHOR]

Considering the current pandemic, caused by the spreading of the novel Coronavirus disease, there is the urgent need for methods to quickly and automatically diagnose infection. To assist pathologists and radiologists in the detection of the novel coronavirus, in this paper we propose a two-tiered method, based on formal methods (to the best of authors knowledge never previously introduced in this context), aimed to (i) detect whether the patient lungs are healthy or present a generic pulmonary infection; (ii) in the case of the previous tier, a generic pulmonary disease is detected to identify whether the patient under analysis is affected by the novel Coronavirus disease. The proposed approach relies on the extraction of radiomic features from medical images and on the generation of a formal model that can be automatically checked using the model checking technique. We perform an experimental analysis using a set of computed tomography medical images obtained by the authors, achieving an accuracy of higher than 81% in disease detection. [ABSTRACT FROM AUTHOR]

(1) Background: Rapid and accurate negative discrimination enables efficient management of scarce isolated bed resources and adequate patient accommodation in the majority of areas experiencing an explosion of confirmed cases due to Omicron mutations. Until now, methods for artificial intelligence or deep learning to replace time-consuming RT-PCR have relied on CXR, chest CT, blood test results, or clinical information. (2) Methods: We proposed and compared five different types of deep learning algorithms (RNN, LSTM, Bi-LSTM, GRU, and transformer) for reducing the time required for RT-PCR diagnosis by learning the change in fluorescence value derived over time during the RT-PCR process. (3) Results: Among the five deep learning algorithms capable of training time series data, Bi-LSTM and GRU were shown to be able to decrease the time required for RT–PCR diagnosis by half or by 25% without significantly impairing the diagnostic performance of the COVID-19 RT–PCR test. (4) Conclusions: The diagnostic performance of the model developed in this study when 40 cycles of RT–PCR are used for diagnosis shows the possibility of nearly halving the time required for RT–PCR diagnosis. [ABSTRACT FROM AUTHOR]

With a global COVID-19 pandemic, the number of confirmed patients increases rapidly, leaving the world with very few medical resources. Therefore, the fast diagnosis and monitoring of COVID-19 are one of the world's most critical challenges today. Artificial intelligence-based CT image classification models can quickly and accurately distinguish infected patients from healthy populations. Our research proposes a deep learning model (WE-SAJ) using wavelet entropy for feature extraction, two-layer FNNs for classification and the adaptive Jaya algorithm as a training algorithm. It achieves superior performance compared to the Jaya-based model. The model has a sensitivity of 85.47±1.84, specificity of 87.23±1.67 precision of 87.03±1.34, an accuracy of 86.35±0.70, and F1 score of 86.23±0.77, Matthews correlation coefficient of 72.75±1.38, and feature mutual information of 86.24±0.76. Our experiments demonstrate the potential of artificial intelligence techniques for COVID-19 diagnosis and the effectiveness of the Self-adaptive Jaya algorithm compared to the Jaya algorithm for medical image classification tasks. [ABSTRACT FROM AUTHOR]

This app project was aimed to remotely deliver diagnoses and disease-progression information to COVID-19 patients to help minimize risk during this and future pandemics. Data collected from chest computed tomography (CT) scans of COVID-19-infected patients were shared through the app. In this article, we focused on image preprocessing techniques to identify and highlight areas with ground glass opacity (GGO) and pulmonary infiltrates (PIs) in CT image sequences of COVID-19 cases. Convolutional neural networks (CNNs) were used to classify the disease progression of pneumonia. Each GGO and PI pattern was highlighted with saliency map fusion, and the resulting map was used to train and test a CNN classification scheme with three classes. In addition to patients, this information was shared between the respiratory triage/radiologist and the COVID-19 multidisciplinary teams with the application so that the severity of the disease could be understood through CT and medical diagnosis. The three-class, disease-level COVID-19 classification results exhibited a macro-precision of more than 94.89% in a two-fold cross-validation. Both the segmentation and classification results were comparable to those made by a medical specialist. [ABSTRACT FROM AUTHOR]

The COVID‐19 pandemic has a significant impact on human health globally. The illness is due to the presence of a virus manifesting itself in a widespread disease resulting in a high mortality rate in the whole world. According to the study, infected patients have distinct radiographic visual characteristics as well as dry cough, breathlessness, fever, and other symptoms. Although, the reverse transcription polymerase‐chain reaction (RT‐PCR) test has been used for COVID‐19 testing its reliability is very low. Therefore, computed tomography and X‐ray images have been widely used. Artificial intelligence coupled with X‐ray technologies has recently shown to be more effective in the diagnosis of this disease. With this motivation, a comparative analysis of fine‐tuned deep learning architectures has been made to speed up the detection and classification of COVID‐19 patients from other pneumonia groups. The models used for this analysis are MobileNetV2, ResNet50, InceptionV3, NASNetMobile, VGG16, Xception, InceptionResNetV2 DenseNet121, which have been fine‐tuned using a new set of layers replaced with the head of the network. This research work has carried out an analysis on two datasets. Dataset‐1 includes the images of three classes: Normal, COVID, and Pneumonia. Dataset‐2, in contrast, contains the same classes with more focus on two prominent pneumonia categories: bacterial pneumonia and viral pneumonia. The research was conducted on 959 X‐ray images (250 of Bacterial Pneumonia, 250 of Viral Pneumonia, 209 of COVID, and 250 of Normal cases). Using the confusion matrix, the required results of different models have been computed. For the first dataset, DenseNet121 has obtained a 97% accuracy, while for the second dataset, MobileNetV2 has performed best with an accuracy of 81%. [ABSTRACT FROM AUTHOR]

The coronavirus disease (COVID-19) pandemic has caused havoc worldwide. The tests currently used to diagnose COVID-19 are based on real time reverse transcription polymerase chain reaction (RT-PCR), computed tomography medical imaging techniques and immunoassays. It takes 2 days to obtain results from the RT-PCR test and also shortage of test kits creating a requirement for alternate and rapid methods to accurately diagnose COVID-19. Application of artificial intelligence technologies such as the Internet of Things, machine learning tools and big data analysis to COVID-19 diagnosis could yield rapid and accurate results. The neural networks and machine learning tools can also be used to develop potential drug molecules. Pharmaceutical companies face challenges linked to the costs of drug molecules, research and development efforts, reduced efficiency of drugs, safety concerns and the conduct of clinical trials. In this review, relevant features of artificial intelligence and their potential applications in COVID-19 diagnosis and drug development are highlighted. [ABSTRACT FROM AUTHOR]